Free Trial
NASDAQ:EYEG

AB Corporate Bond ETF (EYEG) Price, Holdings, & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$35.76
$35.79
50-Day Range
$1.59
$2.25
52-Week Range
$1.44
$8.18
Volume
127 shs
Average Volume
935,975 shs
Market Capitalization
$25.05 million
Assets Under Management
$24.86 million
Dividend Yield
1.97%
Net Expense Ratio
0.30%
EYEG stock logo

About AB Corporate Bond ETF (NASDAQ:EYEG)

EyeGate Pharmaceuticals, Inc. is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes MoxiGel and Ocular Bandage Gel. The company was founded in 1998 and is headquartered in Waltham, MA.

EYEG ETF News Headlines

The Economics Of Corporate Bond Markets
Dave Ramsey Makes Big Mistake Live On Air
Dave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dave Ramsey made a stunning miscalculation while live on air: “Am I worried about this? Absolutely not.” Frankly, I've never seen someone so confident in being wrong… Because what’s happening to the US Dollar is not something you should “keep an eye on”… But instead, is an imminent threat you should get ahead of right NOW.
AB Core Bond ETF (EYEG)
Dave Ramsey Makes Big Mistake Live On Air
Dave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dave Ramsey made a stunning miscalculation while live on air: “Am I worried about this? Absolutely not.” Frankly, I've never seen someone so confident in being wrong… Because what’s happening to the US Dollar is not something you should “keep an eye on”… But instead, is an imminent threat you should get ahead of right NOW.
See More Headlines
Receive EYEG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for AB Corporate Bond ETF and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer
AllianceBernstein
Fund Name
AB Corporate Bond ETF
Tax Classification
Regulated Investment Company
Current Symbol
NASDAQ:EYEG
Inception Date
12/13/2023
Fund Manager
Timothy Kurpis, Bernd Wuebben

Fund Focus

Asset Class
Fixed Income
Benchmark
N/A
Category
Corporate
Focus
Investment Grade
Development Level
Blended Development
Region
Global
Number of Holdings
407

Fund Statistics

Assets Under Management
$24.86 million
Average Daily Volume
$0.00
Discount/Premium
0.11%

Administrator, Advisor and Custodian

Administrator
State Street Bank and Trust Company
Advisor
AllianceBernstein L.P.
Custodian
State Street Bank and Trust Company
Distributor
Foreside Fund Services, LLC
Transfer Agent
State Street Bank and Trust Company
Trustee
N/A
Lead Market Maker
Jane Street

Options

Optionable
N/A
Short Interest
2,400 shs

Miscellaneous

Beta
0.16
Creation Unit
50,000
Creation Fee
$250.00
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

AB Corporate Bond ETF Expenses

TypeEYEGInvestment Grade ETFsFixed Income ETFsNASDAQ ETFsAll ETFs
Management Fee0.30%0.22%0.32%0.48%0.51%
Other Expenses0.00%0.13%0.26%0.39%0.54%
Total Expense0.30%0.25%0.40%0.61%0.71%
Fee Waiver0.00%-0.15%-0.25%-0.32%-0.59%
Net Expense0.30%0.22%0.35%0.54%0.58%

AB Corporate Bond ETF (EYEG)

Key Executives

  • Brian Matthew Strem
    President, Chief Executive Officer & Director
  • Sarah M. Romano
    Chief Financial & Accounting Officer
  • Lisa Brandano
    Vice President-Clinical Operations
  • Franz Obermayr
    Executive Vice President-Clinical Development
  • Brenda K. Mann
    Vice President-Research & Development

EYEG ETF - Frequently Asked Questions

How were AB Corporate Bond ETF's earnings last quarter?

AB Corporate Bond ETF (NASDAQ:EYEG) announced its earnings results on Thursday, August, 12th. The specialty pharmaceutical company reported ($0.35) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.42) by $0.07.

When did AB Corporate Bond ETF IPO?

AB Corporate Bond ETF (EYEG) raised $5 million in an IPO on Friday, February 13th 2015. The company issued 800,000 shares at a price of $6.00 per share. Aegis Capital Corp and Chardan Capital Markets acted as the underwriters for the IPO.

What other stocks do shareholders of AB Corporate Bond ETF own?

Based on aggregate information from My MarketBeat watchlists, some other companies that AB Corporate Bond ETF investors own include Bausch Health Companies (BHC), MannKind (MNKD), Sorrento Therapeutics (SRNE), Idera Pharmaceuticals (IDRA), Celldex Therapeutics (CLDX), Novavax (NVAX) and SCYNEXIS (SCYX).

This page (NASDAQ:EYEG) was last updated on 7/27/2024 by MarketBeat.com Staff

From Our Partners